| Title: |
Patency of coronary side branches covered by an everolimus-eluting bioresorbable vascular scaffold: clinical outcomes and computed tomography scan follow-up |
| Authors: |
Ojeda, Soledad; Pan, Manuel; Suárez de Lezo, Javier; Mazuelos, Francisco; Romero, Miguel; Novoa, José; Espejo, Simona; Segura, José; Morenate, Carmen; Medina, Alfonso; Martin, Pedro; Suarez de Lezo, Jose |
| Contributors: |
8654250900; 7202544866; 55408574200; 7406037925; 24450657100; 7202430759; 24335829400; 7003668552; 55415591100; 56582552600; 7202723590; 56502140300; 343824; 77557; 67522; 1673863; 452208; 156230; 27034269; 4871282; 14736968; 13504958; 74576; 476437; WOS:Ojeda, S; WOS:Pan, M; WOS:de Lezo, JS; WOS:Martin, P; WOS:Mazuelos, F; WOS:Romero, M; WOS:Novoa, J; WOS:Espejo, S; WOS:Segyra, J; WOS:Morenate, C; WOS:Medina, A |
| Source: |
EuroIntervention [ISSN 1774-024X], v. 11 (11), p. e1283-e1290, (Febrero 2016) |
| Publication Year: |
2016 |
| Collection: |
Universidad de Las Palmas de Gran Canaria: Acceda |
| Subject Terms: |
32 Ciencias médicas; Angiography; Bifurcation; Bioresorbable vascular scaffold; Coronary; Multislice computed tomography (MSCT); Percutaneous coronary intervention (PCI); Side branch occlusion |
| Description: |
Aims: The behaviour of side branches (SBs) covered by a bioresorbable vascular scaffold (BVS) is not well known. This study analysed the rate of side branch occlusion (SBO) immediately after BVS implantation, its clinical impact, predictors of SBO and the fate of such SBs at follow-up. Methods and results: We assessed 140 patients with 346 jeopardised SBs divided into three groups: small (2 mm, n=63). SBO was defined as a TIMI flow 0 or 1. Computed tomography was scheduled at six months for patients with jailed SBs >1 mm. Immediate occlusion occurred in 31 (9%) SBs: 22 (12%) small, 8 (8%) intermediate and one (1.6%) large, while post-procedural SBO was 5.5%. In-hospital events included one thrombosis (0.7%) and eight non-Q-wave myocardial infarctions (6%). After 17±3 months, one patient died (0.7%) and six patients needed repeat revascularisation (4%). Re-evaluation showed no late SBO at 7±3 months. Predictors of SBO were: small SBs (OR 2.06, 95% CI: 1.08-4.63; p50% at the origin (OR 17.22, 95% CI: 7.79-38.10; p1 mm were covered. These favourable results were maintained at midterm. ; e1290 ; e1283 ; 8 ; 1,94 ; 5,193 ; Q1 ; Q1 ; SCIE |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
EuroIntervention; 11; WoS; Scopus; https://hdl.handle.net/10553/52618; 84962367607; 000400774200013; Sí |
| DOI: |
10.4244/EIJV11I11A250 |
| Availability: |
https://hdl.handle.net/10553/52618; https://doi.org/10.4244/EIJV11I11A250 |
| Accession Number: |
edsbas.3012DB6D |
| Database: |
BASE |